ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,083,000 | +19.3% | 1,239,555 | +3.8% | 0.00% | +100.0% |
| Q4 2021 | $4,262,000 | +0.8% | 1,193,750 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $4,228,000 | -12.5% | 1,161,372 | +4.8% | 0.00% | -50.0% |
| Q2 2021 | $4,831,000 | +7.8% | 1,107,874 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $4,482,000 | +9.2% | 1,090,439 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $4,103,000 | +48.2% | 1,028,256 | +0.3% | 0.00% | +100.0% |
| Q3 2020 | $2,768,000 | -5.0% | 1,024,980 | -3.3% | 0.00% | 0.0% |
| Q2 2020 | $2,915,000 | +27.8% | 1,059,890 | +9.7% | 0.00% | 0.0% |
| Q1 2020 | $2,281,000 | -48.8% | 966,464 | +1.9% | 0.00% | -50.0% |
| Q4 2019 | $4,457,000 | +40.8% | 948,104 | +0.2% | 0.00% | 0.0% |
| Q3 2019 | $3,165,000 | +4.0% | 946,178 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $3,044,000 | +17.3% | 925,154 | +8.0% | 0.00% | 0.0% |
| Q1 2019 | $2,596,000 | +16.3% | 856,716 | +4.4% | 0.00% | 0.0% |
| Q4 2018 | $2,232,000 | -19.9% | 820,525 | -1.0% | 0.00% | 0.0% |
| Q3 2018 | $2,785,000 | +45.0% | 828,786 | +11.4% | 0.00% | +100.0% |
| Q2 2018 | $1,921,000 | +22.7% | 744,188 | +4.6% | 0.00% | 0.0% |
| Q1 2018 | $1,566,000 | +29.6% | 711,562 | +17.3% | 0.00% | 0.0% |
| Q4 2017 | $1,208,000 | -33.6% | 606,829 | +8.2% | 0.00% | -50.0% |
| Q3 2017 | $1,818,000 | +5.8% | 560,936 | +5.1% | 0.00% | 0.0% |
| Q2 2017 | $1,719,000 | +109.1% | 533,576 | +84.6% | 0.00% | +100.0% |
| Q1 2017 | $822,000 | +34.3% | 289,093 | +10.2% | 0.00% | 0.0% |
| Q4 2016 | $612,000 | +53.0% | 262,246 | +10.2% | 0.00% | – |
| Q3 2016 | $400,000 | +74.7% | 238,068 | +9.4% | 0.00% | – |
| Q2 2016 | $229,000 | -43.7% | 217,598 | -53.5% | 0.00% | -100.0% |
| Q1 2016 | $407,000 | -26.9% | 467,597 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $557,000 | -27.3% | 459,947 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $766,000 | -13.3% | 450,197 | +6.0% | 0.00% | 0.0% |
| Q2 2015 | $884,000 | +2.6% | 424,562 | +33.6% | 0.00% | 0.0% |
| Q1 2015 | $862,000 | +10.9% | 317,893 | +5.2% | 0.00% | 0.0% |
| Q4 2014 | $777,000 | +63.2% | 302,233 | +16.2% | 0.00% | 0.0% |
| Q3 2014 | $476,000 | -30.3% | 260,062 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $683,000 | -32.8% | 255,645 | -11.9% | 0.00% | -50.0% |
| Q1 2014 | $1,016,000 | -10.7% | 290,174 | +14.3% | 0.00% | 0.0% |
| Q4 2013 | $1,138,000 | -2.4% | 253,819 | -5.0% | 0.00% | 0.0% |
| Q3 2013 | $1,166,000 | +4.5% | 267,254 | +1.3% | 0.00% | 0.0% |
| Q2 2013 | $1,116,000 | – | 263,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |